Enerpac Tool Group (NYSE: EPAC) posts 10-quarter-high product growth as EMEA service slump and $51m buyback reshape its fiscal 2026 outlook
How Cambium Networks Corporation’s Nasdaq delisting reshapes investor risk, liquidity, and valuation outlook (NASDAQ: CMBM)
Can SoundHound AI, Inc.’s agentic AI strategy reshape enterprise workflow automation markets? (NASDAQ: SOUN)
Read More 2 minute read Pharma Industry News FDA approves Dompé’s Oxervate for rare eye disease treatment Dompé farmaceutici, an Italian pharmaceutical company, has achieved a milestone with the U.S. Food and Drug Administration (FDA)… bypharmanewsdailyAugust 23, 2018
